Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Wednesday, November 15, 2023

House Passes Delay of PAMA

›
In its brand new budget proprosal, to keep the government open til early 2024, the House passes a full one-year delay of PAMA. The math is a...
Monday, November 13, 2023

Using AI in Real Life: GPT4 Assesses FDA's "BENEFITS" of LDT Proposal

›
Can you use AI in real life?   Here's an example where AI can act as a "second reader" and help you cross-check your opinions,...

A Quote for Your FDA LDT Comments: Shuren Says "We have to change federal law" to fit today's innovations

›
Right now, countless groups are working on comments to submit by December 4, 2023, on the FDA's haywire proposal to regulate LDTs.  I sa...
Sunday, November 12, 2023

Podcast Watch: History and Issues for Genomics Coding (Jim Almas, Perry Dimas, "Promise of Personalized Medicine"

›
In the podcast realm, one new episode of particular interest is, "Deciphering the Code: The Complex World of Genetic Test Coding."...
Friday, November 10, 2023

Decibio: Excellent Hour Webinar on Oncology Reimbursement in Europe

›
This blogs connects you to an excellent multi-expert one hour webinar on reimbursement in Europe, offered last month by Mansfield Advisors a...

A Lawyer's View: Potential Weakness of FDA Regulation of LDTs (Stacy Amin, Morrison Foerster)

›
See an excellent new five page analysis of potential weaknesses in FDA's arguments for its LDT regulating authority.  By Stacy Amin, for...
Thursday, November 9, 2023

AI Corner: Wow, Now, Direct Upload of Science PDFs into ChatGPT 4

›
All year, I've been using Chat GPT4 to summarize things.   Problem was, it was limited to about 2000 words at a go.  (There are " s...

CMS Gives NCD-level coverage to Tempus FDA test; Uses 81479 not 81455

›
CMS closely describes MAC claims handling for tests under NCD 90.2, NGS tests for cancer patients.  They have newly added coverage of the TE...

Trade Journal Watch: 360DX Covers CMS Underpricing of New Cancer GSP Codes

›
 On October 30, I wrote a blog that AMA CPT had added a long series of new comprehensive genomic profiling (CGP) codes for 2024,and that CMS...
Sunday, November 5, 2023

Brief Blog: NEJM Op Ed Supports FDA Control of LDTs

›
A new Op Ed by Singhal et al - from Ann Arbor, Mayo, and Harvard - strongly supports FDA regulation of LDTs.   NEJM pieces like this carry a...
Thursday, November 2, 2023

Very Brief Blog: CMS Posts OPPS, PFS Annual Rules for CY2024

›
 CMS posted annual final rules for PFS and OPPS on the evening of November 2, 2023.  As usually, CMS posts "typescript" versions a...

Brief Blog: MEDPAC discusses Software & CMS Payment Policy

›
On November 2, 2023, MEDPAC , the official body advising on Medicare policy, held a one-hour discussion of CMS policy and payment for softwa...
Wednesday, November 1, 2023

Brief Blog: DECIBIO Survey on FDA LDT Regulations

›
An excellent, 12-page survey from DECIBIO on how the lab industry is viewing the proposals for FDA LDT regulation. Find it here: https://www...

It's Crazy But It's True: Novitas Oncology Public Meeting Vanishes from Website

›
This past summer, the Novitas MAC had a stormy battle with lab stakeholders over a newly restrictive LCD for oncology biomarkers.  One featu...

Journal Club: The Economist: Have Healthcare Costs Stopped Rising (as Share of GDP)

›
Normally, I would only cite an open access article as "journal club" (and in fact you might get a couple free articles a month fro...
‹
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.